Tirofiban‐Associated Profound Thrombocytopenia in a Patient With Glucose‐6‐Phosphate Dehydrogenase Deficiency Undergoing Primary Percutaneous Coronary Intervention: A Case Report
Case Reports in Cardiology · 2026-01 · 2026 (1)
DOI: 10.1155/cric/3617791 ↗Kurz gefasst
Fallbericht in der Zeitschrift Case Reports in Cardiology, online erschienen am 13.05.2026. Verfasst von Chuanwei Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Second People's Hospital of Baoshan City, Baoshan, Yunnan, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Profound thrombocytopenia after tirofiban exposure during primary percutaneous coronary intervention (PCI) is rare but clinically important. Causal attribution may be challenging when unfractionated heparin is coadministered, and the relevance of glucose‐6‐phosphate dehydrogenase (G6PD) deficiency remains uncertain. Case Presentation A 34‐year‐old man with known G6PD deficiency presented with an inferior ST‐segment elevation myocardial infarction and underwent primary PCI. He received aspirin, ticagrelor, and unfractionated heparin. Coronary angiography showed multivessel coronary disease with complete occlusion of the mid‐to‐distal right coronary artery and a large thrombus burden. After aspiration thrombectomy and drug‐eluting stent implantation, intracoronary tirofiban (2500 μ g bolus), followed by intravenous tirofiban infusion (0.15 μ g/kg/min), was administered as bailout antithrombotic therapy. Within 6 h, the platelet count fell from 207 × 10 9 to 1 × 10 9 /L. Peripheral blood smear showed no platelet clumping or abnormal cells. Sepsis and disseminated intravascular coagulation were not supported by laboratory findings. Heparin‐induced thrombocytopenia was considered highly unlikely because the 4Ts score was 1, reflecting the extremely early onset, absence of new thrombosis, and the presence of a more plausible alternative explanation. The clinical course was therefore most consistent with acute tirofiban‐associated profound thrombocytopenia. Interventions and Outcomes Tirofiban and heparin were discontinued immediately, and intravenous immunoglobulin (20 g/day) was administered. The platelet count recovered to 25 × 10 9 /L at 48 h, 48 × 10 9 /L at 72 h, and 124 × 10 9 /L on Day 4. Clopidogrel was restarted at 48 h, followed by indobufen at 72 h. No major bleeding or thrombotic complications occurred.
Conclusions
This case supports tirofiban‐associated acute profound thrombocytopenia as the most likely diagnosis and underscores the importance of prompt drug withdrawal, structured differential diagnosis against heparin‐induced thrombocytopenia, and individualized antithrombotic reinitiation. The contribution of G6PD deficiency remains hypothetical and requires further study.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, The Second People's Hospital of Baoshan City, Baoshan, Yunnan, China.
- Baoshan Traditional Chinese Medicine Hospital, Baoshan, China.
ORCID-Profile: Chuanwei Zhao
Zitieren
APA
Zhao, C., Wang, Y., Gao, S., Meng, W., Yang, Y., & Tan, W. (2026). Tirofiban‐Associated Profound Thrombocytopenia in a Patient With Glucose‐6‐Phosphate Dehydrogenase Deficiency Undergoing Primary Percutaneous Coronary Intervention: A Case Report. Case Reports in Cardiology, 2026(1). https://doi.org/10.1155/cric/3617791
Vancouver
Zhao C, Wang Y, Gao S, Meng W, Yang Y, Tan W. Tirofiban‐Associated Profound Thrombocytopenia in a Patient With Glucose‐6‐Phosphate Dehydrogenase Deficiency Undergoing Primary Percutaneous Coronary Intervention: A Case Report. Case Reports in Cardiology. 2026;2026(1). doi:10.1155/cric/3617791
BibTeX
@article{Zhao2026,
author = {Zhao, Chuanwei and Wang, Yansi and Gao, Shizhen and Meng, Wei and Yang, Yane and Tan, Wenjie},
title = {Tirofiban‐Associated Profound Thrombocytopenia in a Patient With Glucose‐6‐Phosphate Dehydrogenase Deficiency Undergoing Primary Percutaneous Coronary Intervention: A Case Report},
journal = {Case Reports in Cardiology},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/cric/3617791}
}
EUVIMED